FDA 483 - Reproductive Health Center - February 06, 2019

During an inspection, the FDA observed that Reproductive Health Center in Tucson, AZ, failed to establish procedures for HCT/P donor screening, specifically for Zika Virus. Additionally, the firm did not maintain complete documentation of donor screening results for communicable diseases. These issues indicate deficiencies in their quality system for human reproductive tissue.